524602 Stock Overview
Bandaram Pharma Packtech Limited operates in the paper industry in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 3/6 |
Dividends | 2/6 |
Bandaram Pharma Packtech Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹31.07 |
52 Week High | ₹76.59 |
52 Week Low | ₹24.00 |
Beta | -0.93 |
1 Month Change | -24.72% |
3 Month Change | n/a |
1 Year Change | -57.41% |
3 Year Change | n/a |
5 Year Change | -81.28% |
Change since IPO | -40.25% |
Recent News & Updates
Recent updates
Shareholder Returns
524602 | IN Forestry | IN Market | |
---|---|---|---|
7D | -11.3% | -2.3% | -2.5% |
1Y | -57.4% | 41.4% | 44.5% |
Return vs Industry: 524602 underperformed the Indian Forestry industry which returned 39.6% over the past year.
Return vs Market: 524602 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
524602 volatility | |
---|---|
524602 Average Weekly Movement | 9.3% |
Forestry Industry Average Movement | 6.7% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 524602's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 524602's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 14 | Bandaram Reddy | www.bandaram.com |
Bandaram Pharma Packtech Limited operates in the paper industry in India. The company engages in the processing and supply of recycled paper; and trading of paper. It supplies various categories of recycled paper to small and medium size paper mills located primarily in the East and West Godavari Districts of Andhra Pradesh.
Bandaram Pharma Packtech Limited Fundamentals Summary
524602 fundamental statistics | |
---|---|
Market cap | ₹372.84m |
Earnings (TTM) | ₹9.45m |
Revenue (TTM) | ₹305.42m |
39.5x
P/E Ratio1.2x
P/S RatioIs 524602 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524602 income statement (TTM) | |
---|---|
Revenue | ₹305.42m |
Cost of Revenue | ₹251.56m |
Gross Profit | ₹53.86m |
Other Expenses | ₹44.41m |
Earnings | ₹9.45m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.79 |
Gross Margin | 17.63% |
Net Profit Margin | 3.09% |
Debt/Equity Ratio | 31.8% |
How did 524602 perform over the long term?
See historical performance and comparison